Skip to content

CRESCENT BIOPHARMA, INC.: filings

Every CRESCENT BIOPHARMA, INC. annual and quarterly report in the SEC record with the published financial measures it tagged, 50 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-07-30fiscal Q2 2026361020001628280-26-050869
10-Q2026-04-29fiscal Q1 202636770001628280-26-028362
10-K2026-02-26fiscal FY 202541820001628280-26-011983
10-Q2025-11-06fiscal Q3 202532810001628280-25-049868
10-Q2025-07-31fiscal Q2 202531570001628280-25-036839
10-Q2025-05-14fiscal Q1 202531610001558370-25-007780
10-K2025-02-13fiscal FY 202435670001558370-25-000948
10-Q2024-11-13fiscal Q3 202434950001558370-24-015537
10-Q2024-08-08fiscal Q2 202433890001558370-24-011579
10-Q2024-05-09fiscal Q1 202434680001558370-24-007632
10-K2024-03-27fiscal FY 202334880001558370-24-004013
10-Q2023-11-03fiscal Q3 202336990001558370-23-017505
10-Q2023-08-02fiscal Q2 202336950001558370-23-012814
10-Q2023-05-03fiscal Q1 202337730001558370-23-007744
10-K2023-03-29fiscal FY 202237940001558370-23-004864
10-Q2022-11-09fiscal Q3 2022371020001558370-22-017036
10-Q2022-08-03fiscal Q2 202237980001558370-22-011770
10-Q2022-04-28fiscal Q1 202238780001558370-22-006260
10-K2022-03-03fiscal FY 202138970001558370-22-002737
10-Q2021-11-02fiscal Q3 202134910001558370-21-014003
10-Q2021-08-05fiscal Q2 202134870001558370-21-010410
10-Q2021-05-03fiscal Q1 202134700001558370-21-005473
10-K2021-03-02fiscal FY 202034840001558370-21-002222
10-Q2020-11-06fiscal Q3 202034860001558370-20-013021
10-Q2020-07-31fiscal Q2 202034860001558370-20-008841
10-Q2020-05-01fiscal Q1 202033680001558370-20-004879
10-K2020-02-28fiscal FY 201934910001558370-20-001723
10-Q2019-11-07fiscal Q3 201934850001558370-19-010290
10-Q2019-08-01fiscal Q2 201934870001558370-19-006741
10-Q2019-05-02fiscal Q1 201934700001558370-19-003803
10-K2019-03-06fiscal FY 201830860001558370-19-001537
10-Q2018-11-02fiscal Q3 201833820001558370-18-008314
10-Q2018-08-09fiscal Q2 201833820001558370-18-006888
10-Q2018-05-03fiscal Q1 201831640001558370-18-003836
10-K2018-03-06fiscal FY 201730860001558370-18-001553
10-Q2017-11-08fiscal Q3 201731780001558370-17-008486
10-Q2017-08-03fiscal Q2 201730760001558370-17-005782
10-Q2017-05-08fiscal Q1 201727560001558370-17-003731
10-K2017-03-01fiscal FY 201629880001558370-17-001198
10-Q2016-11-04fiscal Q3 201626690001558370-16-009291
10-Q2016-08-04fiscal Q2 201630830001558370-16-007379
10-Q2016-05-04fiscal Q1 201623480001558370-16-005254
10-K2016-02-29fiscal FY 201528900001558370-16-003688
10-Q2015-11-12fiscal Q3 201530830001558370-15-002591
10-Q2015-08-06fiscal Q2 201532880001193125-15-281118
10-Q2015-05-05fiscal Q1 201526530001193125-15-172196
10-K2015-03-16fiscal FY 2014301050001193125-15-093802
10-Q2014-10-31fiscal Q3 201427730001193125-14-391030
10-Q2014-07-31fiscal Q2 201431890001193125-14-289579
10-Q2014-05-09fiscal Q1 201432750001193125-14-192508

Inspect the source

Entity
CRESCENT BIOPHARMA, INC. / CIK 0001253689
Captured
2026-09-20T07:46:49.806Z
SEC response SHA-256
b4a6cd55809d9037713a6469afddaa482d358690abc0227f51b6714b6bda1dce

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001253689.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))